经皮椎体支架系统治疗骨质疏松性椎体压缩性骨折疗效的Meta分析-现代医学

经皮椎体支架系统治疗骨质疏松性椎体压缩性骨折疗效的Meta分析

单位：惠州市第六人民医院脊柱外科, 广东惠州 516000

分类号：R683.2

出版年·卷·期（页码）：2024·52·第九期（1339-1347）

摘要：

目的： 探讨经皮椎体支架系统治疗骨质疏松性椎体压缩性骨折的疗效。方法： 计算机检索PubMed、Cochrane Library、Embase、中国知网、万方、维普数据库中所有涉及经皮椎体支架系统和经皮椎体后凸成形术治疗骨质疏松性椎体压缩性骨折的文献。检索时间限定为建库以来至2023年12月31日。结局指标包括伤椎Cobb角、伤椎Beck指数、疼痛视觉模拟评分、Oswestry功能障碍指数、骨水泥渗漏率、手术时间、术中出血量、骨水泥注入量。利用RevMan 5.4软件进行Meta分析。结果： 9项研究纳入分析，涵盖研究对象562例。Meta分析结果显示：经皮椎体支架系统治疗骨质疏松性椎体压缩性骨折在伤椎Cobb角(MD=-2.47度,95%CI-3.75～-1.19度，P=0.000 2)、伤椎Beck指数(MD=0.18，95%CI 0.01～0.36，P=0.04)以及骨水泥渗漏率(MD=0.48，95%CI 0.28～0.81，P=0.006)方面优于经皮椎体后凸成形术，但前者手术时间更长(MD=5.91 min,95%CI 0.24～11.58 min，P=0.04)、术中骨水泥用量更多(MD=1.45 mL,95%CI 0.30～2.60 mL，P=0.01)，而两者在疼痛视觉模拟评分(MD=-0.18分，95%CI -0.40～0.04分,P=0.12)、Oswestry功能障碍指数(MD=-0.58，95%CI-1.74～0.57，P=0.32)以及术中出血量(MD=0.06 mL，95%CI-0.27～0.38 mL，P=0.73)的比较,差异无统计学意义。结论： 经皮椎体支架系统治疗骨质疏松性椎体压缩性骨折可获得与经皮椎体后凸成形术相当的临床疗效，而且在矫正椎体后凸畸形以及减少骨水泥渗漏方面更具优势。

Objective: To investigate the effect of percutaneous vertebral body stent system in the treatment of osteoporotic vertebral compression fractures. Methods: We searched PubMed, the Cochrane Library, Embase, China National Knowledge Infrastructure, Wanfang database and VIP database for all the articles about the treatment of osteoporotic vertebral compression fracture using vertebral body stent system or percutaneous kyphoplasty from the establishment of databases to December 31st, 2023. The outcome measures included Cobb Angle of fractured vertebrae, Beck Index of fractured vertebrae, Visual Analogue Scale(VAS), Oswestry Dysfunction Index(ODI), bone cement leakage rate, operative time, intraoperative blood loss and bone cement injection. RevMan 5.4 software was used for Meta-analysis. Results: 9 studies including 662 subjects were included in the analysis. The results of Meta-analysis showed that the treatment of osteoporotic vertebral compression fractures with percutaneous vertebral body stent system was superior to percutaneous kyphoplasty in terms of Cobb Angle(MD=-2.47 degree,95%CI-3.75--1.19 degree，P=0.000 2)，Beck Index(MD=0.18，95%CI 0.01-0.36，P=0.04) and bone cement leakage rate(MD=0.48，95%CI 0.28-0.81，P=0.006), but the former had longer operation time(MD=5.91 min，95%CI 0.24-11.58 min，P=0.04) and more bone cement(MD=1.45 mL，95%CI 0.30-2.60 mL，P=0.01). There were no significant differences in VAS score of pain(MD=-0.18，95%CI-0.40-0.04，P=0.12), ODI(MD=-0.58，95%CI-1.74-0.57，P=0.32) and intraoperative blood loss(MD=0.06 mL,95%CI-0.27-0.38 mL，P=0.73) between the two groups. Conclusion: The clinical efficacy of percutaneous vertebral body stent system in the treatment of osteoporotic vertebral compression fractures is comparable to that of percutaneous kyphoplasty, and it has more advantages in the correction of kyphotic deformity and the reduction of bone cement leakage.

参考文献：

[1] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志，2019,25(3):281-309.
[2] 丁悦,张嘉,岳华,等.骨质疏松性椎体压缩性骨折诊疗与管理专家共识[J].中华骨质疏松和骨矿盐疾病杂志，2018,11(5):425-437.
[3] 中国康复医学会骨质疏松预防与康复专业委员会.骨质疏松性椎体压缩骨折诊治专家共识(2021版)[J].中华医学杂志，2021,101(41):3371-3379.
[4] FVRDERER S,ANDERS M,SCHWINDLING B,et al.[Vertebral body stenting.A method for repositioning and augmenting vertebral compression fractures][J].Der Orthopade,2002,31(4):356-361.
[5] HIGGINS J P,ALTMAN D G,GØTZSCHE P C,et al.The Cochrane Collaboration's tool for assessing risk of bias in randomised trials[J].BMJ,2011,343:d5928.
[6] STANG A.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J].Eur J Epidemiol,2010,25(9):603-605.
[7] BECK E.Radiographic measuring methods in vertebral fractures[J].Hefte Unfallheilkd,1971,108:36-37.
[8] JOYCE C R,ZUTSHI D W,HRUBES V,et al.Comparison of fixed interval and visual analogue scales for rating chronic pain[J].Eur J Clin Pharmacol,1975,8(6):415-420.
[9] FAIRBANK J C,COUPER J,DAVIES J B,et al.The Oswestry low back pain disability questionnaire[J].Physiotherapy,1980,66(8):271-273.
[10] 王化瑾,王博.经皮椎体后凸成形术中采用椎体支架系统治疗骨质疏松性椎体压缩性骨折[J].脊柱外科杂志，2023,21(2):87-91.
[11] 赵中男,刘亚明,陈丽娟,等.经皮椎体支架成形术与经皮椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效比较[J].临床军医杂志，2023,51(3):318-320.
[12] 仉培武,郭华,严少荣,等.经皮带球囊支架植入椎体成形术治疗老年骨质疏松性椎体压缩骨折的临床疗效[J].西安交通大学学报(医学版)，2022,43(1):63-68.
[13] 夏坤阳,慈元,李志君,等.经皮椎体支架内固定治疗骨质疏松性椎体压缩骨折的临床研究[J].中医正骨，2022,34(8):1-7.
[14] 赵鹏,慈元,李志君,等.经皮椎体支架成形术治疗骨质疏松性椎体压缩骨折[J].中国矫形外科杂志，2022,30(4):314-318.
[15] 马延怀,张顺聪,袁凯,等.经皮椎体支架成形和经皮椎体后凸成形治疗骨质疏松性椎体压缩骨折的疗效观察[J].中国组织工程研究，2020,24(14):2170-2176.
[16] 贾璞,陈浩,包利,等.改良支架成形术与经皮椎体后凸成形术治疗骨质疏松性椎体压缩骨折近期疗效分析[J].临床和实验医学杂志，2018,17(16):1760-1763.
[17] SCHÜTZENBERGER S,SCHWARZ S M,GREINER L,et al.Is vertebral body stenting in combination with CaP cement superior to kyphoplasty?[J].Eur Spine J,2018,27(10):2602-2608.
[18] THALER M,LECHNER R,NOGLER M,et al.Surgical procedure and initial radiographic results of a new augmentation technique for vertebral compression fractures[J].Eur Spine J,2013,22(7):1608-1616.
[19] 王复案,陈允震.骨质疏松性椎体压缩性骨折诊疗现状及其对策[J].中国骨质疏松杂志，2019,25(5):590-594.
[20] NASTO L A,JANNELLI E,CIPOLLONI V,et al.Three generations of treatments for osteoporotic vertebral fractures:what is the evidence?[J].Orthop Rev,2022,14(6):38609.
[21] 贾崇哲,贾璞,陈浩,等.椎体支架联合可吸收骨水泥治疗骨质疏松性椎体压缩骨折的临床疗效[J].中华创伤杂志，2016,32(9):783-788.
[22] LUO Y,YANG D M,YANG H M,et al.Innovative minimally invasive implants for osteoporosis vertebral compression fractures[J].Front Med,2023,10:1161174.
[23] GAJAVELLI S,GEE A,BAGHERI Z S,et al.A 20-year review of biomechanical experimental studies on spine implants used for percutaneous surgical repair of vertebral compression fractures[J].Biomed Res Int,2022,2022:6015067.
[24] QI Y,ZENG Y,JIANG C,et al.Comparison of percutaneous kyphoplasty versus modified percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].World Neurosurg,2019,122:e1020-e1027.
[25] 龚国梅,初紫晶,陈丽霞,等.经皮椎体成形术对老年骨质疏松性椎体压缩性骨折患者生存质量的影响[J].中国老年学杂志，2017,37(11):2749-2750.
[26] HARTMANN F,GRIESE M,DIETZ S O,et al.Two-year results of vertebral body stenting for the treatment of traumatic incomplete burst fractures[J].Minim Invasive Ther Allied Technol,2015,24(3):161-166.
[27] CIANFONI A,DISTEFANO D,PRAVATÀ E,et al.Vertebral body stent augmentation to reconstruct the anterior column in neoplastic extreme osteolysis[J].J Neurointerv Surg,2019,11(3):313-318.
[28] MOURA D L,ISIDORO D,LOURENÇO P,et al.Stent-armed kyphoplasty in osteoporotic thoracolumbar fractures-clinical and functional results and a center experience over 10 years[J].J Spine Surg,2022,8(4):462-476.
[29] OSWALD K A C,KÄLIN J,TINNER C,et al.Anterior thoracolumbar column reconstruction with the vertebral body stent-safety and efficacy[J].Eur Spine J,2023,32(3):934-949.
[30] GARNON J,DORÉ B,AULOGE P,et al.Efficacy of the vertebral body stenting system for the restoration of vertebral height in acute traumatic compression fractures in a non-osteoporotic population[J].Cardiovasc Intervent Radiol,2019,42(11):1579-1587.
[31] 蔡进奎,罗德民,周健和,等.经皮钛网骨水泥填充治疗骨质疏松性椎体压缩骨折[J].中国矫形外科杂志，2020,28(6):553-556.
[32] ROTTER R,MARTIN H,FUERDERER S,et al.Vertebral body stenting:a new method for vertebral augmentation versus kyphoplasty[J].Eur Spine J,2010,19(6):916-923.
[33] DISCH A C,SCHMOELZ W.Cement augmentation in a thoracolumbar fracture model:reduction and stability after balloon kyphoplasty versus vertebral body stenting[J].Spine,2014,39(19):E1147-E1153.
[34] 王宇翔,徐海栋,赵建宁.椎体成形术治疗骨质疏松性椎体压缩骨折的研究进展[J].生物骨科材料与临床研究，2019,16(6):70-74.
[35] VENDEUVRE T,BROSSARD P,PIC J B,et al.Vertebral balloon kyphoplasty versus vertebral body stenting in non-osteoporotic vertebral compression fractures at the thoracolumbar junction:a comparative radiological study and finite element analysis(BONEXP study)[J].Eur Spine J,2021,30(10):3089-3098.
[36] WERNER C M,OSTERHOFF G,SCHLICKEISER J,et al.Vertebral body stenting versus kyphoplasty for the treatment of osteoporotic vertebral compression fractures:a randomized trial[J].J Bone Joint Surg Am,2013,95(7):577-584.
[37] KANEMATSU R,HANAKITA J,TAKAHASHI T,et al.Intraoperative complications of vertebral body stenting system[J].Surg Neurol Int,2023,14:156.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录